Press release
Automated Insulin Delivery Systems Market Size, Share, and Report 2024-2031
Automated Insulin Delivery Systems Market is expected to reach at a CAGR of 9.7% during the forecast period (2024-2031).Automated insulin delivery systems are designed to assist patients with diabetes, particularly those with type 1 diabetes, in managing their blood glucose levels. These systems, which can be fully automated or semi-automated, adjust insulin delivery automatically based on real-time glucose readings, helping to optimize blood sugar control without requiring constant manual intervention from the patient.
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/automated-insulin-delivery-systems-market
Market Dynamics:
Advancement in next-generation automatic insulin delivery systems is expected to drive market growth.
RocketAP, a new automated insulin delivery (AID) algorithm, has demonstrated promising results in helping adolescents with type 1 diabetes maintain better glucose control after meals, even in the absence of mealtime (bolus) insulin. This innovative algorithm, similar to Control-IQ, features a distinctive capability to detect unscheduled meals and promptly administer bolus insulin, thus reducing the risk of post-meal hyperglycemia. A study utilizing Tandem insulin pumps and Dexcom G6 continuous glucose monitors (CGMs) highlighted impressive outcomes, suggesting that RocketAP could be a significant step toward achieving a fully closed-loop insulin delivery system. These advancements are expected to drive market growth in the upcoming forecast period.
Segment Covered in the Automated Insulin Delivery Systems Market:
By Device Type: Reusable Insulin Pens, Disposable Insulin Pens.
By Insulin Pumps: External/ Tethered Pumps, Implanted Insulin pump (IIP), Patch Pumps, Closed-loop insulin pump, Others.
By Pen Needles: Standard Pen Needles, Safety Pen Needles, Others.
By End-User: Hospitals, Clinics, Homecare, Others.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/automated-insulin-delivery-systems-market
Key players involved in Automated Insulin Delivery Systems Market:
• Medtronic.
• Novo Nordisk.
• Insulet Corporation.
• Tandem Diabetes Care, Inc.
• Ypsomed AG.
• F. Hoffmann-La Roche Ltd.
Related Reports:
Ostomy Drainage Bags Market: https://www.datamintelligence.com/research-report/ostomy-drainage-bags-market
Gastric Balloon Procedures Market: https://www.datamintelligence.com/research-report/gastric-balloon-procedures-market
Infusion Systems Market: https://www.datamintelligence.com/research-report/infusion-systems-market
Product Portfolio:
Medtronic Plc
Medtronic plc is a global medical device company headquartered in Fridley, Minnesota, USA, and incorporated in Ireland. The company specializes in developing and manufacturing a wide range of devices and therapies for over 30 chronic conditions, including heart failure, Parkinson's disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders, and diabetes. Operating in 140 countries, Medtronic employs more than 104,950 people, making it a significant player in the medical technology industry.
Regional Analysis:
The global Automated Insulin Delivery Systems Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Automated Insulin Delivery Systems Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Automated Insulin Delivery Systems Market Size, Share, and Report 2024-2031 here
News-ID: 3643100 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth:
The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031).
The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants…
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth:
The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.
The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for…
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth:
The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033.
The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market…
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth:
The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033.
The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in…
More Releases for Insulin
Insulin Delivery System Advancement Drives the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032.
Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This…
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032.
Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary
This insightful…
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032.
Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary
This insightful…
Insulin Pumps Market Share, Trends and Growth Analysis By Type (Traditional Insu …
Insulin Pumps Market is expected to register a CAGR of 15.5% and acquire the market value of USD 11.5 Billion by 2028 during forecast period 2023-2032. Insulin pumps are discreet, electronic medical devices that can be tucked beneath clothing or fastened to a belt. In order to regulate the rise in blood glucose levels, the pump is used to deliver controlled quantities of insulin within the body at regular intervals…
Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,…
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin…
